Avalo Therapeutics, Inc.
AVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534120
In the last 90 days, Avalo Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $1.31B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Avalo Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +9 vs. Q2 2024
- Shares held
- 6.66M
- +5.89M (+763.7%) vs. Q2 2024
- Total value
- $63.2M
- +$53.6M (+557.6%) vs. Q2 2024
- New holders
- 11
- 3 more added
- Sold out
- 2
- 1 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $1.31B |
| Q1 2026 | 97 | $469.6M |
| Q4 2025 | 84 | $361.1M |
| Q3 2025 | 66 | $194.7M |
| Q2 2025 | 36 | $39.1M |
| Q1 2025 | 34 | $66.1M |
| Q4 2024 | 33 | $56.0M |
| Q3 2024 | 29 | $63.2M |
| Q2 2024 | 21 | $9.62M |
| Q1 2024 | 18 | $1.90M |
| Q4 2023 | 12 | $209.4K |
| Q3 2023 | 28 | $158.9K |
| Q2 2023 | 26 | $862.7K |
| Q1 2023 | 32 | $16.0M |
| Q4 2022 | 28 | $28.0M |
| Q3 2022 | 27 | $18.4M |
| Q2 2022 | 54 | $34.7M |
| Q1 2022 | 71 | $56.2M |
| Q4 2021 | 75 | $136.0M |
| Q3 2021 | 77 | $175.5M |
| Q2 2021 | 71 | $218.1M |
| Q1 2021 | 70 | $180.4M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Avalo Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 970,359 | $9.22M | 2.86% | +915,629+1,673.0% | Added |
| OrbiMed Advisors LLC | 967,000 | $9.19M | 0.17% | +967,000 | New |
| Ra Capital Management, L.P. | 967,000 | $9.19M | 0.11% | +967,000 | New |
| Deep Track Capital, LP | 967,000 | $9.19M | 0.29% | +967,000 | New |
| BVF Inc | 967,000 | $9.15M | 0.27% | +967,000 | New |
| Logos Global Management LP | 539,079 | $5.12M | 0.57% | 00.0% | Unchanged |
| Commodore Capital LP | 483,000 | $4.59M | 0.29% | +443,000+1,107.5% | Added |
| TCG Crossover Management, LLC | 483,000 | $4.59M | 0.39% | +483,000 | New |
| Boothbay Fund Management, LLC | 164,092 | $1.56M | 0.05% | +164,092 | New |
| Sio Capital Management, LLC | 71,458 | $678.9K | 0.30% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 45,000 | $425.7K | 0.07% | 00.0% | Unchanged |
| Vanguard Group Inc | 10,368 | $98.1K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 10,111 | $95.6K | 0.00% | +10,111 | New |
| UBS Group AG | 6,134 | $58.3K | 0.00% | +2,551+71.2% | Added |
| Bank of America Corp | 5,601 | $53.2K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 376 | $3.57K | 0.00% | +376 | New |
| BlackRock, Inc. | 329 | $3.13K | 0.00% | +329 | New |
| Morgan Stanley | 10 | $96 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 4 | $38 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2 | $19 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2 | $19 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2 | $19 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1 | $10 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 1 | $10 | 0.00% | 00.0% | Unchanged |
| Key Financial Inc | 1 | $10 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 1 | $10 | 0.00% | 00.0% | Unchanged |
| Jaffetilchin Investment Partners, LLC | 1 | $10 | 0.00% | +1 | New |
| FMR LLC | 1 | $9 | 0.00% | −1−50.0% | Reduced |
| Avion Wealth | 5 | $0 | 0.00% | +5 | New |
| Royal Bank of Canada | 0 | $0 | 0.00% | −590−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −338−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |